| Title | Placental site trophoblastic tumor presenting as subaponeurotic metastasis. | | Author(s) | Aoki Y, Kase H, Kashima K, Yahata T, Tanaka K | | Institution | Division of Molecular Genetics, Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. yoichi@med.niigata-u.ac.jp | | Source | Int J Gynecol Cancer 2005 Mar-Apr; 15(2):385-8. | | MeSH | Adult
Antineoplastic Combined Chemotherapy Protocols
Bone Neoplasms
Fatal Outcome
Female
Humans
Hysterectomy
Occipital Bone
Placenta Diseases
Pregnancy
Scalp
Skin Neoplasms
Trophoblastic Neoplasms
Uterine Hemorrhage
Uterine Neoplasms
| | Abstract | Cases of metastatic placental site trophoblastic tumor (PSTT) have a very poor prognosis because these tumors tend to be less sensitive to chemotherapy than other types of gestational trophoblastic disease. We describe the case of a 25-year-old woman who presented with occipital tumor and abnormal vaginal bleeding. Hysterectomy, bilateral salpingo-oophorectomy, and occipital tumor removal revealed a primary PSTT in the uterus, with ovarian and occipital subaponeurotic metastases. She received etoposide, methotrexate, actinomycin-D/cyclophosphamide, vincristine chemotherapy and had a complete clinical remission. Fifteen months later, she had a recurrent subaponeurotic occipital tumor invading the cranium and underwent tumor removal along with cranial bone followed by local irradiation. She was then treated with etoposide, cis-platinum/etoposide, methotrexate, actinomycin-D chemotherapy and again had a remission for 5 months. The patient, however, had a left parietal subaponeurotic tumor, invading the dura mater, and received local irradiation. Soon after, she developed left orbital bone metastasis, treated by local irradiation. These bone metastases responded to the radiation completely. However, multiple organ metastases were found, and she died of the disease. This represents the first case of PSTT with initial subaponeurotic metastasis in a living patient. New modalities of treatment for high-risk or metastatic PSTT need to be developed. | | Language | eng | | Pub Type(s) | Case Reports
Journal Article
| | PubMed ID | 15823131 |
|
